---
figid: PMC3514012__fig-5
figtitle: IPA generates IL-17C interactome
organisms:
- Homo sapiens
pmcid: PMC3514012
filename: fig-5.jpg
figlink: /pmc/articles/PMC3514012/figure/f5/
number: F5
caption: IPA generates IL-17C interactome. (A, B) A list of differentially expressed
  genes was obtained by comparing the full microarray data between NCM460-control+Veh.
  and NCM460-control+Fla. With the dataset, IL-17C regulatory interaction network
  mapping in the mammalian system was carried out with IPA, providing 2 potential
  networks linked with IL-17C. Solid and dashed lines represent direct interactions
  and indirect interactions, respectively. IPA, Ingenuity Pathway Analysis CCL2, chemokine
  (C-C motif) ligand 2; CCL3, chemokine (C-C motif) ligand 3; CCL4, chemokine (C-C
  motif) ligand 4; CCL20, chemokine (C-C motif) ligand 20; CSF2, colony stimulating
  factor 2; CX3CL1, chemokine (C-X3-C motif) ligand 1; CXCL1, chemokine (C-X-C motif)
  ligand 1; CXCL2, chemokine (C-X-C motif) ligand 2; CXCL3, chemokine (C-X-C motif)
  ligand 3; DEFB4A, defensin beta 4A; DEFB4B, defensin beta 4B; IFN gamma, interferon
  gamma; IKK, inhibitor kappa B kinase; IL1A, interleukin-1 alpha; IL1B, interleukin-1
  beta; IL8, interleukin 8; IL12, interleukin 12; IL23A, interleukin 23, alpha, subunit
  p19; IL32, interleukin 32; IL36G, interleukin 36 gamma; IRAK2, interleukin-1 receptor-associated
  kinase-like 2; IRF1, interferon regulatory factor 1; GZMB, granzyme B; LCN2, lipocalin-2;
  LTB, lymphotoxin-beta; MAPK, mitogen-activated protein kinases; NF-κB, nuclear factor
  kappa B; NFKB1, nuclear factor kappa B (p105/p50); NFKB1A, inhibitor kappa B alpha
  (IκBα); PTGS2, prostaglandin-endoperoxide synthase 2; REL, nuclear factor kappa
  B (c-Rel); RELB, nuclear factor kappa B (RelB); SAA, serum amyloid A; SERPINB9,
  serpin peptidase inhibitor, clade B, member 9; TNF, tumor necrosis factors; TNFAIP3,
  tumor necrosis factor, alpha-induced protein 3; TRAF1, tumor necrosis factor receptor-associated
  factor 1; TRAF3IP2, tumor necrosis factor receptor-associated factor 3 interacting
  protein 2.
papertitle: Toll-Like Receptor 5 Engagement Induces Interleukin-17C Expression in
  Intestinal Epithelial Cells.
reftext: Eunok Im, et al. J Interferon Cytokine Res. 2012 Dec;32(12):583-591.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8413292
figid_alias: PMC3514012__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3514012__F5
ndex: d498461d-df23-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3514012__fig-5.html
  '@type': Dataset
  description: IPA generates IL-17C interactome. (A, B) A list of differentially expressed
    genes was obtained by comparing the full microarray data between NCM460-control+Veh.
    and NCM460-control+Fla. With the dataset, IL-17C regulatory interaction network
    mapping in the mammalian system was carried out with IPA, providing 2 potential
    networks linked with IL-17C. Solid and dashed lines represent direct interactions
    and indirect interactions, respectively. IPA, Ingenuity Pathway Analysis CCL2,
    chemokine (C-C motif) ligand 2; CCL3, chemokine (C-C motif) ligand 3; CCL4, chemokine
    (C-C motif) ligand 4; CCL20, chemokine (C-C motif) ligand 20; CSF2, colony stimulating
    factor 2; CX3CL1, chemokine (C-X3-C motif) ligand 1; CXCL1, chemokine (C-X-C motif)
    ligand 1; CXCL2, chemokine (C-X-C motif) ligand 2; CXCL3, chemokine (C-X-C motif)
    ligand 3; DEFB4A, defensin beta 4A; DEFB4B, defensin beta 4B; IFN gamma, interferon
    gamma; IKK, inhibitor kappa B kinase; IL1A, interleukin-1 alpha; IL1B, interleukin-1
    beta; IL8, interleukin 8; IL12, interleukin 12; IL23A, interleukin 23, alpha,
    subunit p19; IL32, interleukin 32; IL36G, interleukin 36 gamma; IRAK2, interleukin-1
    receptor-associated kinase-like 2; IRF1, interferon regulatory factor 1; GZMB,
    granzyme B; LCN2, lipocalin-2; LTB, lymphotoxin-beta; MAPK, mitogen-activated
    protein kinases; NF-κB, nuclear factor kappa B; NFKB1, nuclear factor kappa B
    (p105/p50); NFKB1A, inhibitor kappa B alpha (IκBα); PTGS2, prostaglandin-endoperoxide
    synthase 2; REL, nuclear factor kappa B (c-Rel); RELB, nuclear factor kappa B
    (RelB); SAA, serum amyloid A; SERPINB9, serpin peptidase inhibitor, clade B, member
    9; TNF, tumor necrosis factors; TNFAIP3, tumor necrosis factor, alpha-induced
    protein 3; TRAF1, tumor necrosis factor receptor-associated factor 1; TRAF3IP2,
    tumor necrosis factor receptor-associated factor 3 interacting protein 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF6
  - TRAF7
  - NFKBIA
  - NFKB2
  - RELA
  - RELB
  - REL
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - IRAK2
  - LCN2
  - GZMB
  - NFKB1
  - IL36G
  - CXCL2
  - TRAF3IP2
  - CXCL3
  - CSF2
  - CCL2
  - IFNG
  - IFNA1
  - IL32
  - SAA1
  - SAA2
  - SAA4
  - IRF1
  - IL23A
  - IL12A
  - IL12B
  - ADGRL3
  - IL17C
---
